Stuart Bond
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 20
-
- Antifungal resistance and susceptibility 2
- Co-authors
- Mamoon A. Aldeyab (18 shared papers)Barbara R. Conway (16 shared papers)Syed Shahzad Hasan (6 shared papers)Sidra Khan (5 shared papers)Spiros Miyakis (7 shared papers)Craig S. Boutlis (5 shared papers)W W Yeo (4 shared papers)Sayer Al‐Azzam (6 shared papers)
- Journals
- Antibiotics (6 papers)Expert Review of Anti-infective Therapy (5 papers)Infection Control and Hospital Epidemiology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)JMIR Medical Education (1 paper)
- Partner nations
- United KingdomAustraliaJordan
In The Last Decade
Stuart Bond
24 papers receiving 311 citations
Peers
Comparison fields: 5 of 59
- Applied Microbiology and Biotechnology 193
- Molecular Medicine 45
- Geriatrics and Gerontology 26
- Critical Care and Intensive Care Medicine 16
- Clinical Biochemistry 18
Countries citing papers authored by Stuart Bond
This map shows the geographic impact of Stuart Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Bond more than expected).
Fields of papers citing papers by Stuart Bond
This network shows the impact of papers produced by Stuart Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Bond. The network helps show where Stuart Bond may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Bond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 65 | |
| 2 | 2017 | 39 | |
| 3 | 2020 | 37 | |
| 4 | 2017 | 26 | |
| 5 | 2017 | 24 | |
| 6 | 2018 | 18 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 10 | |
| 9 | 2020 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2022 | 9 | |
| 12 | Patients with suspected myocardial infarction: effect of mode of referral on admission time to a coronary care unit. | 1992 | 8 |
| 13 | 2017 | 6 | |
| 14 | 2016 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Stuart Bond
Stuart Bond is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, General Health Professions, Epidemiology and Molecular Medicine, having authored 28 papers that have together received 318 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (20 papers), Patient Satisfaction in Healthcare (3 papers), Antibiotic Resistance in Bacteria (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Antifungal resistance and susceptibility (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Emergency and Acute Care Studies (2 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (193 citations), Molecular Medicine (45 citations), Geriatrics and Gerontology (26 citations), Critical Care and Intensive Care Medicine (16 citations) and Clinical Biochemistry (18 citations). Stuart Bond has collaborated with scholars based in United Kingdom, Australia and Jordan. Frequent co-authors include Mamoon A. Aldeyab, Barbara R. Conway, Syed Shahzad Hasan, Sidra Khan, Spiros Miyakis, Craig S. Boutlis, W W Yeo, Sayer Al‐Azzam, Brendan McMullan and Ping Yu. Their work appears in journals such as Antibiotics, Expert Review of Anti-infective Therapy, Infection Control and Hospital Epidemiology, Journal of Antimicrobial Chemotherapy and JMIR Medical Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.